Kenneth A Andreoni
Overview
Explore the profile of Kenneth A Andreoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Altshuler P, Bodzin A, Andreoni K, Singh P, Yadav A, Glorioso J, et al.
Transplant Direct
. 2024 Dec;
11(1):e1744.
PMID: 39703726
Background: Deceased donor multiorgan transplants utilizing kidneys (MOTs) can improve outcomes for multiorgan recipients but reduces kidneys for chronic renal failure patients. Methods: We reviewed the Organ Procurement and Transplantation...
2.
Seth R, Andreoni K
Front Transplant
. 2024 Aug;
3:1449407.
PMID: 39176402
Since the first liver transplant was performed over six decades ago, the landscape of liver transplantation in the US has seen dramatic evolution. Numerous advancements in perioperative and operative techniques...
3.
Preston W, Pace D, Altshuler P, Yi M, Kittle H, Vincent S, et al.
Am J Transplant
. 2023 Nov;
24(4):619-630.
PMID: 37940005
The recent shortage of the University of Wisconsin (UW) solution prompted increased utilization of histidine-tryptophan-ketoglutarate (HTK) solution for liver graft preservation. This contemporary study analyzed deceased donor liver transplant outcomes...
4.
Khong J, Lee M, Warren C, Kim U, Duarte S, Andreoni K, et al.
medRxiv
. 2023 Jul;
PMID: 37397983
Background: Inter- and intra-individual variability in tacrolimus dose requirements mandates empirical clinician-titrated dosing that frequently results in deviation from a narrow target range. Improved methods to individually dose tacrolimus are...
5.
Andreoni K
Curr Opin Organ Transplant
. 2021 Dec;
27(1):70-74.
PMID: 34939966
Purpose Of Review: Kidney transplantation is a heavily regulated medical procedure with the Secretary of HHS ultimately responsible for oversight and authority derived from the NOTA and the Final Rule....
6.
Andreoni K, Zarrinpar A
JAMA Surg
. 2021 Aug;
156(11):1034-1035.
PMID: 34379089
No abstract available.
7.
Santos Jr A, Leghrouz M, Bueno E, Andreoni K
Int Urol Nephrol
. 2021 Jul;
54(3):637-646.
PMID: 34216339
Purpose: We conducted this observational study to examine the impact of antibody inductions administered at kidney transplant (KT) on outcomes of 5 year exposure to post-transplant diabetes (PTDM) in adult...
8.
Witkowski P, Odorico J, Pyda J, Anteby R, Stratta R, Schrope B, et al.
J Clin Med
. 2021 Jul;
10(13).
PMID: 34209541
The Food and Drug Administration (FDA) has been regulating human islets for allotransplantation as a biologic drug in the US. Consequently, the requirement of a biological license application (BLA) approval...
9.
10.
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update
Witkowski P, Philipson L, Kaufman D, Ratner L, Abouljoud M, Bellin M, et al.
Am J Transplant
. 2020 Nov;
21(4):1365-1375.
PMID: 33251712
Islet allotransplantation in the United States (US) is facing an imminent demise. Despite nearly three decades of progress in the field, an archaic regulatory framework has stymied US clinical practice....